✦ LIBER ✦

Percutaneous coronary intervention and the use of glycoprotein IIb/IIIa inhibitors in patients with chronic kidney disease on dialysis: A single center experience

✍ Scribed by Azam KHAJA; Rajeev GARG; Gurushanker GOVINDARAJAN; Richard MADSEN; Kul AGGARWAL

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of Low Molecular Weight Heparins and

✍ Mark A. Perazella; Ari Mosenkis; Jeffrey S. Berns 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Impact of race and chronic kidney diseas

✍ Francesca Cardarelli; Antonio Bellasi; Emir Veledar; Viola Vaccarino; Paolo Ragg 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Decreased complication rates using the t

✍ Jonas Eichhöfer; Eric Horlick; Joan Ivanov; Peter H. Seidelin; John R. Ross; Dou 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Effectiveness and safety of glycoprotein

✍ Remi Kouz; Simon Kouz; Erick Schampaert; Stephane Rinfret; Jean-Claude Tardif; M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 759 KB

TCT-472: Impact of Different Glycoprotei

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 215 KB

A Comparison of Intracoronary with Intra

✍ GANG FU; LEI JIA; XIN ZHAO; YIBO WANG; XIAOHUI CHEN; YANG YANG; NA LU; WEI ZHAO; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 793 KB